The SPHKI/S1P/S1PR1 signaling activates AKT, JAK2/STAT3, and cMYC and enhances the levels of the cancerous inhibitor of protein phosphatase 2A (CIP2A) downstream to promote the pro-survival phenotype in glioblastoma cells [97]. This evidence concerns the gene S1PR1 and glioblastoma.